Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Grafting versus Crosslinking of Silk Fibroin-g-PNIPAM via Tyrosine-NIPAM Bridges.

Radu IC, Biru IE, Damian CM, Ion AC, Iovu H, Tanasa E, Zaharia C, Galateanu B.

Molecules. 2019 Nov 13;24(22). pii: E4096. doi: 10.3390/molecules24224096.

2.

Adverse and hormetic effects in rats exposed for 12 months to low dose mixture of 13 chemicals: RLRS part III.

Docea AO, Goumenou M, Calina D, Arsene AL, Dragoi CM, Gofita E, Pisoschi CG, Zlatian O, Stivaktakis PD, Nikolouzakis TK, Kalogeraki A, Izotov BN, Galateanu B, Hudita A, Calabrese EJ, Tsatsakis A.

Toxicol Lett. 2019 Aug;310:70-91. doi: 10.1016/j.toxlet.2019.04.005. Epub 2019 Apr 16.

PMID:
30999039
3.

Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer.

Radu IC, Hudita A, Zaharia C, Galateanu B, Iovu H, Tanasa EV, Georgiana Nitu S, Ginghina O, Negrei C, Tsatsakis A, Velonia K, Shtilman M, Costache M.

Drug Deliv. 2019 Dec;26(1):318-327. doi: 10.1080/10717544.2019.1582729.

4.

Chemoprevention of Colorectal Cancer by Dietary Compounds.

Costea T, Hudiță A, Ciolac OA, Gălățeanu B, Ginghină O, Costache M, Ganea C, Mocanu MM.

Int J Mol Sci. 2018 Nov 28;19(12). pii: E3787. doi: 10.3390/ijms19123787. Review.

5.

Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies.

Taghizadehghalehjoughi A, Hacimuftuoglu A, Cetin M, Ugur AB, Galateanu B, Mezhuev Y, Okkay U, Taspinar N, Taspinar M, Uyanik A, Gundogdu B, Mohammadzadeh M, Nalci KA, Stivaktakis P, Tsatsakis A, Jung TW, Jeong JH, Abd El-Aty AM.

Nanomedicine (Lond). 2018 Jul;13(13):1595-1606. doi: 10.2217/nnm-2017-0386. Epub 2018 Jul 20.

PMID:
30028222
6.

In Vitro Effects of Cetylated Fatty Acids Mixture from Celadrin on Chondrogenesis and Inflammation with Impact on Osteoarthritis.

Hudita A, Galateanu B, Dinescu S, Costache M, Dinischiotu A, Negrei C, Stan M, Tsatsakis A, Nikitovic D, Lupuliasa D, Balanescu A.

Cartilage. 2018 May 1:1947603518775798. doi: 10.1177/1947603518775798. [Epub ahead of print]

PMID:
29808705
7.

Update on radionuclide therapy in oncology.

Nitipir C, Niculae D, Orlov C, Barbu MA, Popescu B, Popa AM, Pantea AMS, Stanciu AE, Galateanu B, Ginghina O, Papadakis GZ, Izotov BN, Spandidos DA, Tsatsakis AM, Negrei C.

Oncol Lett. 2017 Dec;14(6):7011-7015. doi: 10.3892/ol.2017.7141. Epub 2017 Oct 5.

8.

Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer.

Radu IC, Hudita A, Zaharia C, Stanescu PO, Vasile E, Iovu H, Stan M, Ginghina O, Galateanu B, Costache M, Langguth P, Tsatsakis A, Velonia K, Negrei C.

Front Pharmacol. 2017 Aug 2;8:508. doi: 10.3389/fphar.2017.00508. eCollection 2017.

9.

Worldwide legislative challenges related to psychoactive drugs.

Negrei C, Galateanu B, Stan M, Balalau C, Dumitru MLB, Ozcagli E, Fenga C, Kovatsi L, Fragou D, Tsatsakis A.

Daru. 2017 Jun 2;25(1):14. doi: 10.1186/s40199-017-0180-2. Review.

10.

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment.

Negrei C, Hudita A, Ginghina O, Galateanu B, Voicu SN, Stan M, Costache M, Fenga C, Drakoulis N, Tsatsakis AM.

Front Pharmacol. 2016 Jun 23;7:172. doi: 10.3389/fphar.2016.00172. eCollection 2016.

11.

Impact of multicellular tumor spheroids as an in vivo‑like tumor model on anticancer drug response.

Galateanu B, Hudita A, Negrei C, Ion RM, Costache M, Stan M, Nikitovic D, Hayes AW, Spandidos DA, Tsatsakis AM, Ginghina O.

Int J Oncol. 2016 Jun;48(6):2295-302. doi: 10.3892/ijo.2016.3467. Epub 2016 Apr 1.

12.

A 3D Porous Gelatin-Alginate-Based-IPN Acts as an Efficient Promoter of Chondrogenesis from Human Adipose-Derived Stem Cells.

Dinescu S, Galateanu B, Radu E, Hermenean A, Lungu A, Stancu IC, Jianu D, Tumbar T, Costache M.

Stem Cells Int. 2015;2015:252909. doi: 10.1155/2015/252909. Epub 2015 May 27.

13.

In Vitro Studies of Bacterial Cellulose and Magnetic Nanoparticles Smart Nanocomposites for Efficient Chronic Wounds Healing.

Galateanu B, Bunea MC, Stanescu P, Vasile E, Casarica A, Iovu H, Hermenean A, Zaharia C, Costache M.

Stem Cells Int. 2015;2015:195096. doi: 10.1155/2015/195096. Epub 2015 May 28.

14.

In vitro cytocompatibility evaluation of chitosan/graphene oxide 3D scaffold composites designed for bone tissue engineering.

Dinescu S, Ionita M, Pandele AM, Galateanu B, Iovu H, Ardelean A, Costache M, Hermenean A.

Biomed Mater Eng. 2014;24(6):2249-56. doi: 10.3233/BME-141037.

PMID:
25226924
15.

Bioevaluation of novel anti-biofilm coatings based on PVP/Fe3O4 nanostructures and 2-((4-ethylphenoxy)methyl)-N- (arylcarbamothioyl)benzamides.

Limban C, Missir AV, Grumezescu AM, Oprea AE, Grumezescu V, Vasile BS, Socol G, Trușcă R, Caproiu MT, Chifiriuc MC, Gălățeanu B, Costache M, Morușciag L, Pîrcălăbioru G, Nuță DC.

Molecules. 2014 Aug 12;19(8):12011-30. doi: 10.3390/molecules190812011.

16.

Perilipin expression reveals adipogenic potential of hADSCs inside superporous polymeric cellular delivery systems.

Dinescu S, Galateanu B, Lungu A, Radu E, Nae S, Iovu H, Costache M.

Biomed Res Int. 2014;2014:830791. doi: 10.1155/2014/830791. Epub 2014 May 4.

17.

Biocompatibility assessment of novel collagen-sericin scaffolds improved with hyaluronic Acid and chondroitin sulfate for cartilage regeneration.

Dinescu S, Gălăţeanu B, Albu M, Lungu A, Radu E, Hermenean A, Costache M.

Biomed Res Int. 2013;2013:598056. doi: 10.1155/2013/598056. Epub 2013 Nov 7.

18.

Modulation of adipogenic conditions for prospective use of hADSCs in adipose tissue engineering.

Galateanu B, Dinescu S, Cimpean A, Dinischiotu A, Costache M.

Int J Mol Sci. 2012 Nov 27;13(12):15881-900. doi: 10.3390/ijms131215881.

19.

Sericin enhances the bioperformance of collagen-based matrices preseeded with human-adipose derived stem cells (hADSCs).

Dinescu S, Galateanu B, Albu M, Cimpean A, Dinischiotu A, Costache M.

Int J Mol Sci. 2013 Jan 16;14(1):1870-89. doi: 10.3390/ijms14011870.

20.

Osteoblast cell behavior on the new beta-type Ti-25Ta-25Nb alloy.

Cimpean A, Mitran V, Ciofrangeanu CM, Galateanu B, Bertrand E, Gordin DM, Iordachescu D, Gloriant T.

Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1554-63. doi: 10.1016/j.msec.2012.04.042. Epub 2012 Apr 29.

PMID:
24364960

Supplemental Content

Loading ...
Support Center